← Open Payments lookup

AIMEE COCKERHAM: Open Payments

NPI 1669086096 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,429 in 63 payments from 14 companies in 2025. Trend: 2023 $425 · 2024 $258 · 2025 $1,429

Food & beverage: $1,429
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.9$238
ABBVIE INC.13$228
Phathom Pharmaceuticals, Inc.8$218
Gilead Sciences, Inc.3$125
QOL Medical, LLC4$93
Regeneron Healthcare Solutions, Inc.3$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Madrigal Pharmaceuticals4$82
Janssen Biotech, Inc.4$74
Lilly USA, LLC4$67

Products named: ENTYVIO, VOQUEZNA, RINVOQ, Sucraid, DUPIXENT, XIFAXAN, REZDIFFRA, TREMFYA.

Industry payments across MS — which companies pay providers there.